NY-ESTÉE-LAUDER
16.7.2024 07:31:34 CEST | Business Wire | Press release
The Estée Lauder Companies (NYSE: EL) (“ELC”) is pleased to announce the third edition of BEAUTY&YOU India. Created by ELC’s New Incubation Ventures (“NIV”) and launched in partnership with India’s preferred beauty and lifestyle retailer - NYKAA, BEAUTY&YOU India continues its mission to discover, spotlight, and propel the next generation of India-focused beauty brands. The program supports India-focused companies, entrepreneurs, innovators, and creators through a competitive application process that will be open to prospective applicants on July 16, 2024, through August 29, 2024, via www.beautyandyouawards.com. Winners will be announced on November 16, 2024, at a live event in Goa.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240715092980/en/
Introducing BEAUTY&YOU India 2024: Fueling Innovation in the Indian Beauty Landscape (Photo: Business Wire)
The 2024 program builds on the success of previous years with the theme of Supercharged Futures. The beauty opportunity in India continues to grow with more brands, increased innovation, significant investment dollars, and a consumer base looking for the best solutions. BEAUTY&YOU India 2024 seeks applicants with a supercharged vision for the future of Indian beauty and its impact on the broader beauty ecosystem. This encompasses companies with social initiatives that enhance the lives of their communities and the ecosystems in which they operate. It also includes founders who are developing new technologies, ingredients, or solutions that address existing challenges for Indian beauty consumers while driving innovation across Skin Care, Makeup, Hair Care and Fragrance categories.
An exciting addition to this year's program is that winners will have access to the BEAUTY&YOU India Bootcamp, featuring one-on-one mentorship sessions with industry leaders Falguni Nayar, Founder & Chief Executive Officer, NYKAA; Sabyasachi Mukherjee, Founder, Sabyasachi; and Rohan Vaziralli, General Manager, ELCA Cosmetics Private Limited. This unique opportunity is designed to provide the winners with invaluable insights and mentorship from these experts and affirms the program’s commitment to fostering the growth and development of the next generation of Indian-focused beauty entrepreneurs.
From the first edition in 2022 to the second in 2023, the applicant pool doubled in size. This growth has significantly enhanced the visibility and opportunities for the winners, underscoring the program's positive impact.
“India represents one of the most exciting global economies for beauty today. A growing consumer base, an exciting retail landscape, and one of the most powerful entertainment markets in the world continue to fuel unprecedented growth. The market is poised to continue to drive both national and global trends. We are excited to support the founders and creators in their journey,” said Shana Randhava, Senior Vice President, New Incubation Ventures, ELC.
"The global recognition of India’s potential as both a powerful consumer market and entrepreneurial hub is more evident now than ever before. NYKAA is proud to be a part of nurturing this ecosystem,” said Anchit Nayar, Executive Director & CEO, NYKAA Beauty. “In its third edition, BEAUTY&YOU India is more than just a platform — it's a gateway for Indian entrepreneurs to showcase their creativity and rigor on a global stage and we are excited to be part of their future.”
"Participating in BEAUTY&YOU India since its first edition has been an immensely rewarding experience, particularly in seeing its transformative impact on the Indian beauty industry. The program enhances the trajectory of emerging brands by providing a platform that fosters growth, innovation, and visibility,” said 2024 BEAUTY&YOU India judge Katrina Kaif, Actor and Co-Founder, Kay Beauty, “In my role as the co-founder of Kay Beauty, I have a deep appreciation for such platforms that support entrepreneurs in their journey. As we enter the third edition, I am as excited and committed as ever to discover and support brands that are shaping the future of beauty in India."
2024 Prize Program
The following prizes are open to founders, companies, and creatives meeting specific application criteria available at www.beautyandyouawards.com/application-criteria. The following awards will be presented across categories in Skin Care, Make Up, Hair Care, Personal Fragrance, and Home Fragrance:
- IMAGINE: Pre-Launch Beauty Concepts
- GROW: In-Market Beauty Concepts
- CREATE: The Next Generation of Creative Talent (e.g., photographers, filmmakers, etc.) Submitting Work Around the Theme of ‘Supercharged Futures’
Among other resources, BEAUTY&YOU India 2024 will provide award recipients with financial support (a prize pool up to 4 Crore or $500k), distribution channel access, mentorship, and access to research and innovation resources.
The BEAUTY&YOU 2024 website and application portal go live July 16, 2024, and will accept applications until August 29, 2024, 11:59 PM IST. Full program details are available at www.beautyandyouawards.com.
2024 Judges
Shana Randhava
Senior Vice President, New Incubation Ventures, The Estée Lauder Companies
Anchit Nayar
Executive Director & CEO, NYKAA Beauty
Katrina Kaif
Actor and Co-Founder, Kay Beauty
Gaurav Gupta
Couturier, Artist and Designer
Anaita Shroff Adajania
Stylist, Creative Director & Founder, Style Cell
Samrath Bedi
Executive Director, Forest Essentials
Diipa Büller-Khosla
Founder, indē wild
Sandhya Devanathan
Vice President & Head – India, Meta
Rohan Vaziralli
General Manager, ELCA Cosmetics Private Limited
Jaffrey Zaman
Managing Director, Intercos India Private Limited
Gianandrea Ferrari
CEO, Intercos Europe, Middle East & India
Sumit Bhasin
Senior Vice President, Global Fragrance Innovation, Product Development & R&D, The Estée Lauder Companies
Dr. Jaishree Sharad
Celebrated Cosmetic Dermatologist, author and TEDx Speaker
Shruti Chandra,
Vice President, Invest India and Vice Chair, Women Empowerment, Europe India Council for Business and Industry (EICBI)
Rochelle Pinto
Head of Editorial Content, Vogue India
Sujata Assomull
Contributing Editor, Vogue Business
Deepica Mutyala
Founder and CEO, Live Tinted
About BEAUTY&YOU India
BEAUTY&YOU aims to help founders, innovators and creators grow their businesses holistically by identifying brand goals, achieving scale ambitions and curating product portfolios that speak to a new generation of Indian consumers.
About The Estée Lauder Companies’ New Incubation Ventures
New Incubation Ventures (NIV) is the strategic early-stage investment and incubation arm for The Estée Lauder Companies. NIV partners with forward-thinking founders and entrepreneurs to create, fund, and support the best-emerging beauty brands and new business models to shape the future of beauty and build an actionable pipeline of diversified brands and new engines of growth for the ELC portfolio.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD.
About NYKAA
Born out of a desire to make beauty a mainstream choice, Nykaa began in 2012 as a digitally native, consumer-tech company. Through founder Falguni Nayar’s vision to bring inspiration and joy to people everywhere, it tapped into an underserved beauty retail market, disrupting the ecosystem and putting India in the global spotlight. Today, Nykaa has expanded its offerings to include lifestyle and B2B by introducing online platforms Nykaa Fashion, Nykaa Man and Superstore.
Over the years, Nykaa has steadily captured the hearts of Indian consumers, ushering visits to its online and 175 offline destinations and building loyal communities through engaging and educational content. Nykaa continues to build its house of brands with a sharp focus on innovation and consumer delight. Beauty brands such as Kay Beauty, Nykaa Naturals, Nykaa Cosmetics and Wanderlust along with fashion brands such as Nykd, Gajra Gang, Likha, RSVP and Pipa Bella have become household names as they consistently deliver inspiration and high-performing products to the consumers.
Nykaa’s unwavering commitment to authenticity and putting the customer at the heart of everything that they do has made it the retailer of choice for international brands entering India. Its Global Store, a gateway into the world of coveted international brands, leverages the company’s proven supply chain and marketing capabilities to offer a truly seamless shopping experience.
Website: www.beautyandyouawards.com
Instagram: @beautyandyouawards
ELC-C
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240715092980/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom